An Ovine Model Yields Histology and Gene Expression Changes Consistent with Laryngotracheal Stenosis

Laura Mafla,Raymond J. So,Samuel L. Collins,Yee Chan‐Li,Ioan Lina,Kevin M. Motz,Alexander T. Hillel
DOI: https://doi.org/10.1002/lary.31499
IF: 2.97
2024-05-15
The Laryngoscope
Abstract:Large animal models are needed to assess novel therapies for laryngotracheal stenosis (LTS) prior to human translation. In this manuscript, we describe a large ovine model for LTS and show that airway stenosis can be reliably and safely produced via combined chemo‐mechanical injury. We additionally show that stent placement is feasible and safe. Objectives Animal models for laryngotracheal stenosis (LTS) are critical to understand underlying mechanisms and study new therapies. Current animal models for LTS are limited by small airway sizes compared to human. The objective of this study was to develop and validate a novel, large animal ovine model for LTS. Methods Sheep underwent either bleomycin‐coated polypropylene brush injury to the subglottis (n = 6) or airway stent placement (n = 2) via suspension microlaryngoscopy. Laryngotracheal complexes were harvested 4 weeks following injury or stent placement. For the airway injury group, biopsies (n = 3 at each site) were collected of tracheal scar and distal normal regions, and analyzed for fibrotic gene expression. Lamina propria (LP) thickness was compared between injured and normal areas of trachea. Results No mortality occurred in sheep undergoing airway injury or stent placement. There was no migration of tracheal stents. After protocol optimization, LP thickness was significantly increased in injured trachea (Sheep #3: 529.0 vs. 850.8 um; Sheep #4: 933.0 vs. 1693.2 um; Sheep #5: 743.7 vs. 1378.4 um; Sheep #6: 305.7 vs. 2257.6 um). A significant 62‐fold, 20‐fold, 16‐fold, 16‐fold, and 9‐fold change of COL1, COL3, COL5, FN1, and TGFB1 was observed in injured scar specimen relative to unaffected airway, respectively. Conclusion An ovine LTS model produces histologic and transcriptional changes consistent with fibrosis seen in human LTS. Airway stent placement in this model is safe and feasible. This large airway model is a reliable and reproducible method to assess the efficacy of novel LTS therapies prior to clinical translation. Level of Evidence N/A Laryngoscope, 2024
medicine, research & experimental,otorhinolaryngology
What problem does this paper attempt to address?